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CASE PRESENTATION
A 15-year-old African-American male was hospitalized for
evaluation of new onset edema, proteinuria, and rising
creatinine. The patient had a history of sickle cell anemia
(Hgb SS) and multiple vaso-occlusive crises requiring
exchange transfusions. One day prior to admission, he had
presented to the Emergency Department with left flank
pain, where he was treated with i.v. ketorolac and
morphine sulfate, and was discharged. The following day
he returned to the Emergency Department with recurrent
flank pain, which was now bilateral, and progressive facial
and ankle edema.
There was no antecedent upper respiratory tract
infection, fever, weight loss, rash, chest pain, or dyspnea.
He experienced some nausea with one episode of emesis.
He denied dysuria, gross hematuria, and nephrolithiasis.
Except for the ketorolac given in the Emergency
Department, there was no history of nonsteroidal
anti-inflammatory drug use. His only medications
included folate, amoxicillin, and acetaminophen with
codeine. Family history was negative for renal disease.
On physical examination, the patient was an
ill-appearing, well-developed young man weighing 57 kg.
He was afebrile with blood pressure of 132/72 mmHg and
heart rate of 108 b.p.m. Cardiac exam was remarkable for
regular tachycardia with a soft mid-systolic murmur. The
lungs were clear. The left flank was tender to percussion.
There was hepatomegaly with a smooth liver edge
palpable 3 cm below the costal margin. There was facial
and periorbital edema as well as 1þ bilateral ankle
edema.
Laboratory evaluation showed a creatinine of 1.7 mg/dl
(150mmol/l) (normal range 0.7–1.5 mg/dl (62–133mmol/l),
which had increased from his baseline level of 0.6 mg/dl
(53mmol/l) 2 months earlier. Other laboratory values
included BUN of 21 mg/dl (7.5 mmol/l) (normal range
9–21 mg/dl (3.2–7.5 mmol/l)), albumin 1.6 g/dl (16 g/l)
(normal range 3–5 g/dl (30–50 g/l)), hemoglobin 8.7 g/dl
(87 g/l) (normal range 13–16 g/dl (130–160 g/l)), which
further decreased to 6.8 g/dl over the next 3 days,
reticulocyte count 5.1% (normal range 0.5–1.5%), total
leukocyte count 20 900/mm3 (normal range 4500–
13 500/mm3) with a normal differential, and platelets
762 000/mm3 (normal range 150 000–450 000/mm3).
The serum electrolytes were normal. Urinalysis showed
3þ protein and 3þ heme with 0–3 WBC/hpf, 1–5
RBC/hpf, and no cellular casts. The 24-h urine protein was
15.488 g. Total cholesterol was 256 mg/dl (6.62 mmol/l)
(normal range, 130–200 mg/dl (3.36–5.17 mmol/l)).
Erythrocyte sedimentation rate was 113 mm/h (normal
range 0–10 mm/h) and C-reactive protein was 2.8 mg/dl
(normal range 0–1 mg/dl). The following serologies were
negative: antinuclear antibody, antineutrophil cytoplasmic
antibody, antiglomerular basement membrane antibody,
human immunodeficiency virus (HIV) antibody, hepatitis B
surface antigen, and hepatitis C antibody. Complement
levels were normal. Antistreptolysin O antibody titer was
elevated at 187 IU/ml (normal range o100 IU/ml). Renal
ultrasound showed enlarged echogenic kidneys measuring
14.2 and 13.8 cm, without evidence of hydronephrosis,
papillary necrosis, or renal vein thrombosis.
The patient was felt to be in sickle crisis and
was treated with exchange transfusions. Over the next
several days, his creatinine rose progressively to
3.0 mg/dl (265mmol/l). Empiric high-dose intravenous
methylprednisolone was initiated on the fourth hospital
day pending the results of renal biopsy.
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KIDNEY BIOPSY FINDINGS
Light microscopic evaluation revealed renal cortex containing
24 glomeruli, of which one was globally sclerotic. Four
glomeruli contained irregular segmental lesions of
sclerosis with adhesion to Bowman’s capsule. All glomeruli
displayed severe intracapillary erythrocyte congestion and
sickling (Figure 1a). Of these glomeruli, 16 exhibited
collapsing lesions of sclerosis with predominantly global
wrinkling and retraction of glomerular basement membranes
(GBMs) and hypertrophy and hyperplasia of the overlying
podocytes, some of which contained intracytoplasmic
protein resorption droplets (Figures 1b and c). In two
glomeruli, there was exuberant podocyte hyperplasia forming
pseudocrescents. Periodic acid Schiff and silver stains
delineated widespread narrow replication of GBMs produ-
cing double contours associated with occasional mesangial
interposition (Figure 1d). Many of the collapsed glomeruli
also displayed mesangiolysis, as well as focal intracapillary
margination of neutrophils and monocytes with mild
endothelial swelling. There was mild focal tubular atrophy
and interstitial fibrosis affecting approximately 5–10% of the
cortex. Proximal tubules contained abundant proteinaceous
casts that focally distended the lumen, forming tubular
microcysts. Proximal tubular epithelial cells contained
numerous intracytoplasmic protein resorption droplets.
Many proximal tubules also appeared simplified with loss
of brush border, attenuated epithelium, and enlarged
reparative nuclei with nucleoli. No cortical infarction was
identified. Arteries and arterioles were unremarkable. Me-
dulla was not sampled.
Immunofluorescence revealed 1þ semilinear glomerular
capillary wall staining for fibrinogen, 1þ granular
mesangial and semilinear glomerular capillary wall
staining for IgM, and 2þ segmental tuft staining for
C3 in areas of sclerosis. Immunohistochemistry performed
on paraffin sections using rabbit antiparvovirus
antibody (Dako Corporation, Carpinteria, CA, USA) was
negative.
By electron microscopy, glomerular capillaries were
focally occluded by GBM collapse with overlying podocyte
hyperplasia (Figure 1e). Some of the collapsed segments
displayed detachment of podocytes from the GBM with
intervening layering of neomembrane material. Podocytes
contained focal intracytoplasmic protein resorption
droplets. Foot-process effacement involved over 90% of the
glomerular capillary surface area. The glomerular capillaries
lumina were also compromised by widespread erythrocyte
sickling associated with focal platelet aggregates and en-
dothelial cell swelling (Figure 1f). Some of the sickled
erythrocytes contained elongated rod-shaped intracellular
inclusions typical of polymerized hemoglobin. Several
glomerular capillaries displayed circumferential mesangial
interposition and duplication of GBMs. No immune-type
electron dense deposits or endothelial tubuloreticular inclu-
sions were seen. The tubules displayed focal degenerative
changes.
PATHOLOGIC DIAGNOSIS
Sickle cell glomerulopathy with collapsing focal segmental
glomerulosclerosis (FSGS), massive intracapillary sickling,
and membranoproliferative features.
CLINICAL FOLLOW-UP
The patient was maintained on oral prednisone 60 mg daily,
and captopril therapy was initiated 3 days following biopsy.
After 2 days, he developed blurred vision and right arm
numbness. Head computed tomography scan revealed frontal
and parietal infarcts in the distribution of the middle cerebral
artery, and the patient was started on hydroxyurea and
hypertransfusion protocol. Magnetic resonance angiography
demonstrated several hyperintense foci with lack of enhance-
ment consistent with foci of hypoperfusion in the anterior
cortex of both kidneys, with patent renal arteries and veins.
At 3 months after biopsy, serum creatinine is 1.9 mg/dl
(168 mmol/l) and the patient remains fully nephrotic despite
treatment with steroids and captopril. Steroids are currently
being tapered.
DISCUSSION
Patients with sickle cell disease (SCD) are known to develop
many potential functional and structural renal abnormalities.
Because the relatively hypoxic, hypertonic milieu of the renal
medulla promotes sickling at the level of the vasa recta,
patients may develop urinary concentrating defects, impaired
potassium excretion, renal insufficiency, gross hematuria,
papillary necrosis, and pyelonephritis. Glomerular involve-
ment takes a variety of morphologic forms and may present
clinically with proteinuria and renal insufficiency. In a large
prospective study of 381 patients with SCD reported by Falk
et al.,1 proteinuria (41þ on a dipstick) developed in 26% of
patients and renal insufficiency occurred in 6.7% of patients.
In another prospective study, 30% of 787 patients with SCD
developed chronic renal failure.2 Nephrotic syndrome devel-
oped in 12 (5%) of 240 patients with SCD in the
retrospective series reported by Bakir et al.3
Glomerular hypertension and hyperfiltration are thought
to play a major role in the development of glomerular disease
in patients with SCD. A supranormal glomerular filtration
rate may be found in SCD patients with or without clinically
evident renal disease, correlating with the presence of
glomerulomegaly. In some patients, the glomerular filtration
rate subsequently normalizes and progressively decreases with
age. Potential causes for the glomerular hypertension and
hypertrophy include altered renal medullary production of
prostaglandins, promoting vasodilatation of the afferent
arteriole, as well as increased serum viscosity. The most
common glomerular lesions seen in patients with SCD
associated with proteinuria are the classic and perihilar forms
of focal and segmental glomerulosclerosis,1,3–5 membranopro-
liferative glomerulonephritis type 1 with immune deposits,6,7
and a membranoproliferative pattern without immune
deposits that resembles chronic thrombotic microangiopa-
thy.3,8 Cases of sickle cell glomerulopathy with mixed focal
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Figure 1 | (a) Many glomerular capillaries are congested with sickled erythrocytes (hematoxylin and eosin, original magnification
 600). (b) A representative glomerulus shows global collapse of the glomerular capillaries with wrinkling of GBMs. The overlying podocytes
are hypertrophied and hyperplastic with intracytoplasmic protein resorption droplets and vacuoles (arrows) (Jones methenamine silver, JMS,
original magnification  400). (c) A glomerulus displays exuberant glomerular epithelial hyperplasia overlying the collapsed capillaries. Some of
the collapsed capillaries also display duplication of GBM (JMS, original magnification  600). (d) There is widespread narrow duplication of
GBMs with focal mesangial interposition (arrows) (Periodic acid Schiff, original magnification  600). (e) The glomerular capillary lumen is
occluded by collapse of the glomerular capillary wall, which appears duplicated. There is complete foot process effacement and the overlying
podocytes appear swollen and hyperplastic (electron micrograph, original magnification  2000). (f) A glomerular capillary is narrowed by
mesangial interposition and duplication of GBM as well as intraluminal sickling of erythrocytes. One of the sickled erythrocytes contains rod-
shaped inclusions consistent with polymerized hemoglobin (arrow). The endothelial fenestrations are obliterated and there is complete foot
process effacement (electron micrograph, original magnification  3000).
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sclerosing and membranoproliferative features are not un-
common in clinical practice. Other glomerular lesions reported
rarely in patients with SCD include acute postinfectious
glomerulonephritis and membranous glomerulopathy.
The typical focal sclerosing lesion of SCD is a perihilar
variant of focal segmental sclerosis associated with glomerulo-
megaly.1 In the report of 381 patients with SCD by Falk
et al.,1 the perihilar variant of FSGS was found in eight of 10
patients who underwent renal biopsy. In the remaining two
patients, there was focal global, but not segmental, glomerulo-
sclerosis. Most of the patients had clinically mild disease;
24-h urine protein excretion ranged from 0.8 to 2.2 g in nine
patients and reached 10.8 g in the tenth patient. Serum
creatinine was p1.8 mg/dl (159 mmol/l) in all 10 patients. In
contrast to our patient, in whom the proteinuria was
refractory to angiotensin converting enzyme inhibitor and
steroid treatment, their 10 patients experienced a 57% mean
decrease in proteinuria after 2 weeks of treatment with
enalapril alone.1
Bhathena and Sondheimer5 analyzed the renal biopsies
from six nephrotic patients with SCD. They observed two
patterns of FSGS: an expansile lesion of segmental sclerosis in
which the sclerotic segment was expanded by increased
matrix material and a second pattern characterized by GBM
wrinkling, retraction of the sclerotic segment, and mesangial
atrophy. Although they labeled the latter a ‘collapsing pattern
of sclerosis’, the pattern illustrated5 does not meet modern
definitions of the collapsing variant of FSGS because it lacks
glomerular epithelial cell hypertrophy and hyperplasia.9
Our case is unusual for the development of collapsing
glomerulopathy and florid nephrotic syndrome in association
with massive intracapillary sickling and a co-existent
membranoproliferative pattern with features of chronic
thrombotic microangiopathy (including GBM double con-
tours, mesangiolysis, and endothelial cell swelling). Collap-
sing glomerulopathy is a distinct morphologic variant of
(FSGS) defined by segmental or global collapse of GBMs
associated with overlying podocyte hypertrophy and hyper-
plasia9 (Table 1). It usually presents with severe markers of
nephrotic syndrome and rapidly progressive renal failure.
Most cases of collapsing glomerulopathy occur in African-
American patients with HIV-associated nephropathy10 or as an
idiopathic variant of FSGS.11 Secondary collapsing glomerulo-
pathy has also been reported in association with pamidronate
treatment12 and parvovirus B19 infection.13 In addition, there
are rare case reports of collapsing glomerulopathy occurring in
patients with adult onset Still’s disease,14 pulmonary tuber-
culosis,15 and acute cytomegalovirus infection.16
This report describes the first case of collapsing FSGS
associated with sickle cell glomerulopathy. The heavy nephrotic
syndrome and absence of glomerulomegaly argue against
collapsing FSGS as an adaptive response to hyperfiltration in
SCD. The patient was HIV-negative, providing evidence against
HIV-associated nephropathy. Parvovirus B19 infection was
unlikely based on the negative immunostains for the virus and
the absence of history of aplastic crisis. Although we cannot
exclude co-incidental idiopathic collapsing FSGS in this
African-American patient, the presence of membranoproli-
ferative features with mesangiolysis and extensive intraglomer-
ular sickling suggests the possibility of a secondary form of
collapsing FSGS due to sickle cell glomerulopathy. This
interpretation is further supported by the dramatic develop-
ment of acute nephrotic syndrome during a systemic sickle
crisis heralded by bilateral flank pain and stroke.
We can only speculate on the pathomechanism of
collapsing glomerulopathy in our patient with sickle cell
glomerulopathy. The association with marked intraglome-
rular sickling and systemic sickle crisis with magnetic resonance
angiography findings of bilateral zones of renal cortical
hypoperfusion suggests the possibility of acute vaso-
occlusion as a precipitating factor. Precedents for acute renal
vaso-occlusive events in the pathogenesis of collapsing glo-
merulopathy include atheroembolic disease17 and renal
allografts with microvascular injury due to acute thrombotic
microangiopathy or transplant arteriopathy.18,19 The inter-
esting observation that the collapsing glomerulopathy
identified in allograft nephrectomies typically occurs in a
zonal distribution that parallels the distribution of the
occlusive vascular lesions strongly supports a role for local
ischemia.19 We have also seen collapsing features in renal
biopsies from patients with acute renal vaso-occlusion due to
classic polyarteritis nodosa, malignant hypertension and
hemolytic uremic syndrome (unpublished observations).
The development of collapsing glomerulopathy in all these
conditions resembles the experimental model of collapsing
glomerulopathy in mice with overexpression of the 164
isoform of vascular endothelial growth factor-A.20 In this
model, it has been proposed that podocyte overexpression of
vascular endothelial growth factor-A promotes coalescence of
endothelial cells, with secondary reduction in glomerular
capillary flows and pressures, leading to luminal collapse.20
This report of collapsing FSGS in SCD enlarges the
spectrum of clinical conditions associated with collapsing
FSGS. The development of acute collapsing glomerulopathy
during sickle crisis in this patient with massive intraglomer-
ular sickling and other morphologic features of sickle cell
glomerulopathy supports the possibility of acute microvas-
cular occlusion as a major pathogenetic factor.
Table 1 | Conditions associated with collapsing
glomerulopathy
Conditions References
Idiopathic 11
HIV-associated nephropathy 10
Pamidronate toxicity 12
Parvovirus B19 infection 13
Renal allografts with microvascular injury 18,19
Atheroembolic disease 17
Adult onset Still’s diseasea 14
Pulmonary tuberculosisa 15
Acute cytomegalovirus infectiona 16
Sickle cell diseasea Current case
aRare association limited to single or few case reports.
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